Table: Brightpath Biotherapeutics -2021/22 parent forecast

BrightPath Biotherapeutics Co

01/04/2022 09:20

Apr 1 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2022      Mar 31, 2022   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           17 mln             2 mln      
  Operating      loss 1.85         loss 1.85    
  Recurring      loss 1.85         loss 1.85    
  Net            loss 1.85         loss 1.85    
  EPS         loss 36.49 yen    loss 36.49 yen  
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T